
Healthcare
Stocks for companies doing business related to medical and healthcare goods or services including hospital management firms, health maintenance organizations (HMOs), biotechnology and a variety of medical products.

In February 2019 a ban on junk food advertising across the London public transport system was enforced in a move to curb child obesity. A […]

CoronaVirus Becomes World’s Costliest Epidemic at over $62bn, Says Report
The ravaging Coronavirus has become the world’s costliest epidemic in the last 20 years. According to data collected by Learnbonds.com the CoronaVirus, which has mostly […]

Johnson & Johnson Stock: 2020 Outlook Indicates Sustainable Growth
Johnson & Johnson (NYSE: JNJ) stock price soared sharply in the past few months on the back of prospects for sustainable revenue and earnings growth. […]

Abbott Stock Fly to New All-Time High On Robust Earnings Growth
Abbott (NYSE: ABT) stock price surged to a new all-time high following strong than expected revenue and earnings growth in the final quarter of 2019. […]

AbbVie Stock Is Perfect for Dividend Portfolio
AbbVie (NYSE: ABBV) stock appears like a good play for dividend investors due to its history of increasing dividends at a double-digit rate. In addition, […]

Chemesis International Inc Gets Accredited To Produce CBD Products
Chemesis International Inc seems to start this week with a good note, especially following its recent news where it was licensed by Puerto Rico to […]

Top 7 Biotech Stocks to Invest in August
Biotech is one of the most promising sectors of the economy that bring you growth, risk, and excitement. For those investors who like to delve […]

Johnson & Johnson Begins Disbursing Compensation for Faulty Hip Implants
US Pharma company Johnson & Johnson was recently directed by the Delhi High Court to pay ₹25 lakh each to all the patients who received […]

Bayer AG Welcomes Judge’s Decision to reduce $2 Billion in Damages
German Pharma Company Bayer AG today welcomed a US judge’s call to reduce $2 billion damages award in a case related to its glyphosate-based weed […]

Novartis International Reports Double-Digit Growth in Core Operating income
Novartis International AG recently posted its financial results for the second quarter of 2019. The company experienced stronger sales during the three-month period alongside double-digit […]